Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 14 citing articles:

Case report: Local anesthesia with lidocaine infiltration for extended-release buprenorphine therapy
Pouya Azar, Jin‐Tae Kim, Ella Rohani, et al.
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Treatment satisfaction and patient reported outcomes among people with opioid use disorder participating in an open‐label, non‐randomised trial of long‐acting injectable buprenorphine treatment in Australian custodial settings
Bethany White, Sophia C. Little, Paul Haber, et al.
Drug and Alcohol Review (2025)
Open Access
Investigating outcomes in a substance use treatment provider: a cross-sectional comparison of long-acting injectable buprenorphine and oral medication for opioid use disorder
Catharine Montgomery, Yasir Abbasi, Devon De Silva, et al.
BMJ Open (2025) Vol. 15, Iss. 2, pp. e090736-e090736
Open Access
Retention and dropout from sublingual and extended-release buprenorphine treatment: A comparative analysis of data from a nationally representative sample of commercially-insured people with opiod use disorder in the United States
Roman Ivasiy, Lynn M. Madden, Kimberly Johnson, et al.
International Journal of Drug Policy (2025) Vol. 138, pp. 104748-104748
Closed Access
Characterizing withdrawal from long-acting injectable buprenorphine: an observational case series.
Victoria Hayes, Llewellyn Mills, GAYE BYRON, et al.
Drug and Alcohol Dependence Reports (2025), pp. 100329-100329
Open Access
Long-Acting Injectable Buprenorphine for Opioid Use Disorder: A Qualitative Analysis of Patients’ Interpersonal Relationships during the First Year of Treatment
Joanne Neale, John Strang
Substance Use & Misuse (2024) Vol. 59, Iss. 14, pp. 2064-2072
Open Access | Times Cited: 2
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
Pouya Azar, Hannah Schneiderman, Henry Barron, et al.
Addiction Science & Clinical Practice (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Effectiveness of long-acting buprenorphine – A systematic review
John McMaster, Hesitha Abeysundera
Australasian Psychiatry (2024)
Closed Access | Times Cited: 1
Evaluating preferences for medication formulation and treatment model among people who use opioids non-medically: A web-based cross-sectional study
Elizabeth C. Saunders, Alan J. Budney, Patricia Cavazos‐Rehg, et al.
Journal of Substance Use and Addiction Treatment (2024) Vol. 163, pp. 209383-209383
Closed Access
Provider costs of treating opioid dependence with extended‐release buprenorphine in Australia
Stella Settumba, Jeyran Shahbazi, Marianne Byrne, et al.
Drug and Alcohol Review (2024)
Open Access
A Single‐Dose Study to Evaluate the Relative Bioavailability, Safety, and Tolerability of Monthly Extended-Release Buprenorphine at Alternative Injection Locations in Adult Participants with Opioid Use Disorder
Céline M. Laffont, Olga Lapeyra, Dipti Mangal, et al.
Clinical Drug Investigation (2024)
Open Access
Giving Up the Guidelines: A Qualitative Evaluation of Disrupted Prescribing of Opioid Substitution Therapy in a Rural UK County During and Following the COVID-19 Pandemic
Tim Lewington, Deanne Burch, Georges Petitjean
International Journal of Environmental Research and Public Health (2024) Vol. 21, Iss. 12, pp. 1605-1605
Open Access
Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098 an open-label randomized comparative effectiveness trial of extended-release buprenorphine versus treatment as usual on post-hospital treatment engagement for hospitalized patients with opioid use disorder
Gavin Bart, Kelly S. Barth, Paulette Baukol, et al.
Addiction Science & Clinical Practice (2024) Vol. 19, Iss. 1
Open Access
Capturing the Full Range of Buprenorphine Treatment Response
Allen J. Bailey, Victoria R. Votaw, Roger D. Weiss, et al.
JAMA Psychiatry (2024)
Closed Access
Patient experience of opioid use disorder treatment medications: a systematic review of contemporary qualitative research
Natalie Lowry, Carina Najia, Mike Kelleher, et al.
BMJ Open (2024) Vol. 14, Iss. 12, pp. e088617-e088617
Open Access
Page 1

Scroll to top